MediWound (MDWD) Director Samuel Rubinstein Sells and Rebuys 525 Shares

What Happened

• Samuel Rubinstein, a director of MediWound Ltd. (MDWD), executed offsetting open-market trades on 2026-09-01: he sold 525 shares at $12.72 ($6,678) and purchased 525 shares at $12.62 ($6,626). The trades leave his net share position unchanged; the transactions were effectively offsetting with a small net cash difference (~$52).

Key Details

• Transaction dates and prices: 2026-09-01 — Sale: 525 shares @ $12.72; Purchase: 525 shares @ $12.62.
• Reported values: Sale proceeds $6,678; Purchase cost $6,626.
• Shares owned after transaction: Not specified in the provided filing excerpt (some rows noted as informational only).
• Relevant footnotes from the filing:
  • F1: Some ordinary shares reported relate to RSUs granted Mar 4, 2026 that vest 100% on the one-year anniversary of the grant date.
  • F3: Options were granted Mar 4, 2026 and vest 100% on the one-year anniversary.
  • F2: Certain rows were included for informational purposes only and reflect no transactions.
• Timeliness and compliance: Report filed 2026-09-02 covering transactions on 2026-09-01. The issuer is a foreign private issuer; the reporting person is exempt from Section 16(b) short-swing profit recovery under Rule 3a12-3(b).

Context

• The filing does not state a reason for the offsetting sale and purchase. Offsetting trades like these are commonly routine (e.g., brokerage rebalancing or cash management), but no motive is disclosed in the form.